These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10225570)

  • 1. Ten years of ciprofloxacin: the past, present and future. Pharmacokinetics. Introduction.
    Wise R
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():41. PubMed ID: 10225570
    [No Abstract]   [Full Text] [Related]  

  • 2. Ten years of ciprofloxacin: the past, present and future. Serious hospital infections. Introduction.
    Wilcox MH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():115. PubMed ID: 10225581
    [No Abstract]   [Full Text] [Related]  

  • 3. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 4. The administration of ciprofloxacin during continuous renal replacement therapy: pilot study.
    Hayakawa M; Fujita I; Iseki K; Gando S
    ASAIO J; 2009; 55(3):243-5. PubMed ID: 19318919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin concentration in bone tissue.
    Meissner A; Borner D
    J Chemother; 1989 Jul; 1(4 Suppl):552-3. PubMed ID: 16312528
    [No Abstract]   [Full Text] [Related]  

  • 6. Aqueous and vitreous penetration of topically applied ciprofloxacin and ofloxacin.
    Taustine LR
    J Cataract Refract Surg; 2004 Jan; 30(1):6. PubMed ID: 14967251
    [No Abstract]   [Full Text] [Related]  

  • 7. Bronchopulmonary penetration of ciprofloxacin.
    Loos U; Marklein G; Scholl H
    J Chemother; 1989 Jul; 1(4 Suppl):560-1. PubMed ID: 16312532
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative bioavailability of two oral formulations of ciprofloxacin.
    Trejo D; Toledo A; Carrasco-Portugal Mdel C; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of chloroquine on the bioavailability of ciprofloxacin in man.
    Ilo EC; Orisakwe OE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo J; Agbasi PU
    J Control Release; 2006 Nov; 116(2):e109-10. PubMed ID: 17718943
    [No Abstract]   [Full Text] [Related]  

  • 10. Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species.
    Cox SK; Cottrell MB; Smith L; Papich MG; Frazier DL; Bartges J
    J Vet Pharmacol Ther; 2004 Jun; 27(3):139-46. PubMed ID: 15189299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers.
    Washington CB; Hou SY; Campanella C; Hughes N; Brown S; Berner B
    J Clin Pharmacol; 2005 Nov; 45(11):1236-44. PubMed ID: 16239356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transepithelial intestinal excretion of ciprofloxacin in humans.
    Ramon J; Ben-Haim M; Shabtai M; Rubinstein E
    Clin Infect Dis; 2001 Mar; 32(5):822-3. PubMed ID: 11229852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of topically applied ciprofloxacin in tears of mesocephalic and brachycephalic dogs.
    Hendrix DV; Cox SK
    Vet Ophthalmol; 2008; 11(1):7-10. PubMed ID: 18190345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial impregnation of cartilage implants with ciprofloxacin.
    Maier H; Zielinski D; Adler D
    J Chemother; 1989 Jul; 1(4 Suppl):554-5. PubMed ID: 16312529
    [No Abstract]   [Full Text] [Related]  

  • 16. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P; Gastonguay MR
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of topically applied ciprofloxacin in equine tears.
    Hendrix DV; Stuffle JL; Cox SK
    Vet Ophthalmol; 2007; 10(6):344-7. PubMed ID: 17970994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers.
    Schuck EL; Grant M; Derendorf H
    J Clin Pharmacol; 2005 Jul; 45(7):822-31. PubMed ID: 15951472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses.
    Odoul F; Le Guellec C; Giraut C; de Gialluly C; Marchand S; Paintaud G; Saux MC; Rolland JC; Autret-Leca E
    Therapie; 2001; 56(5):519-24. PubMed ID: 11806288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.